Nurix Therapeutics, Inc. - Common stock (NQ:NRIX)

22.90 -0.09 (-0.38%)

Delayed Quote Updated: 12:28 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Nurix Therapeutics, Inc. - Common stock

< Previous 1 2 3 4 5 Next >

Key Takeaways From Nurix Therapeutics Analyst Ratings ↗

May 14, 2024

Via Benzinga

Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 12, 2024

Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

Via Benzinga

Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

April 12, 2024

U.S. stock futures were mixed this morning, with the Dow futures gaining over 50 points on Friday.

Via Benzinga

Topics Stocks

Critical Insights From Nurix Therapeutics Analyst Ratings: What You Need To Know ↗

April 02, 2024

Via Benzinga

Analyst Scoreboard: 7 Ratings For Nurix Therapeutics ↗

March 11, 2024

Via Benzinga

Decoding 4 Analyst Evaluations For Nurix Therapeutics ↗

February 16, 2024

Via Benzinga

Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket ↗

April 12, 2024

Shares of NextPlat Corp (NASDAQ: NXPL) rose sharply in today’s pre-market trading after the company reported consolidated 2023 revenues of $37.8 million, up 222% year over year

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 11, 2024

Via Benzinga

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 11, 2024

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.

Via Benzinga

The Latest Analyst Ratings for Nurix Therapeutics ↗

October 13, 2023

Via Benzinga

What 4 Analyst Ratings Have To Say About Nurix Therapeutics ↗

September 07, 2023

Via Benzinga

Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday ↗

April 11, 2024

U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NASDAQ: ELVN) rose sharply during Thursday’s session.

Via Benzinga

Topics Stocks

NRIX Stock Earnings: Nurix Therapeutics Beats EPS, Misses Revenue for Q1 2024 ↗

April 10, 2024

NRIX stock results show that Nurix Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 09, 2024

Via Benzinga

BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday ↗

April 09, 2024

U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) rose sharply during Tuesday’s session.

Via Benzinga

Topics Stocks

Analyst Ratings for Nurix Therapeutics ↗

July 24, 2023

Via Benzinga

Nurix Therapeutics's Return On Capital Employed Insights ↗

July 14, 2023

Via Benzinga

Analyst Ratings for Nurix Therapeutics ↗

April 14, 2023

Via Benzinga

Bit Digital, Cipher Mining And Other Big Stocks Moving Higher In Thursday's Pre-Market Session ↗

December 28, 2023

U.S. stock futures were mixed this morning, with the Dow Jones futures falling around 40 points on Thursday. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Topics Stocks

Judith A. Reinsdorf and Katherine M. Sandstrom Named to Toll Brothers Board of Directors

December 13, 2023

From Toll Brothers, Inc.

Via GlobeNewswire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 11, 2023

Via Benzinga

Nurix Therapeutics Inc. (NASDAQ: NRIX) Highlighted for Surprising Price Action

April 13, 2023

Via Investor Brand Network

Expert Ratings for Nurix Therapeutics ↗

March 21, 2023

Via Benzinga

Gilead Exercises First License Option Under Agreement With Nurix Therapeutics ↗

March 20, 2023

Via Benzinga

Cathie Wood-Led Ark Invest Sells Over $6.5M Worth Of Tesla Stock, What's Going On? ↗

October 17, 2023

Via Benzinga

Why Is Cancer Focused Nurix Therapeutics Stock Trading Higher Today? ↗

September 07, 2023

Nurix Therapeutics Inc (NASDAQ: NRIX) has entered into a multi-year, multi-target strategic collaboration agreement with Seagen Inc (NASDAQ: SGEN) to advance a new class of medicines called...

Via Benzinga

Designer Brands, Calavo Growers, Couchbase And Other Big Stocks Moving Higher On Thursday ↗

September 07, 2023

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Analyst Cuts Nurix Therapeutics Price Target By 38%, Cites Lymphoma Data ↗

July 24, 2023

HC Wainwright analyst Robert Burns has lowered the price target for Nurix Therapeutics Inc (NASDAQ: NRIX)

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

July 14, 2023

It's time to start the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

JPMorgan, Citigroup, QuidelOrtho And Other Big Stocks Moving Higher On Friday ↗

April 14, 2023

U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.